John Morrey

Publications | Abstracts

• Morrey, J.D, Siddharthan, V., Wang, H., Motter, N.E, Hall, J.O, (2010). Discovery and treatment of respiratory neurologic sequelae in west nile virus infected hamsters . Antiviral Res.
• Morrey, J.D, (2001). Transgenic mice carrying a gene for green fluorescent protein fused to a lytic peptide, shiva 1, under control of the bovine B-casein regulatory region. Transgenics *
• Morrey, J.D, (1999). Transgenic mice as a chemotherapeutic model for hepatitis B virus infection. Antiviral Ther. *
• Morrey, J.D, (1995). Effect of the combination of interferon-alpha and stavudine on Friend virus infections in (B10.A X A.By)F1 mice. Journal of Infectious Diseases *
• Morrey, J.D, (1994). Cytokines as potential therapies for human immunodeficiency virus infections. Canadian Journal of Infectious Diseases *
• Morrey, J.D, (1992). Ganciclovir treatment of murine cytomegalovirus infection in mice immunosuppressed by prior infection with friend leukemia virus. Antiviral Chemistry and Chemotherapy
• Morrey, J.D, (1992). Transgenic mice as models for photo-induced gene expression: Activation of human immunodeficiency virus long terminal repeat. Journal of Photochemistry and Photobiology *
• Morrey, J.D, Bourn, S.M, Bunch, T.D, Sidwell, R.W, Barrows, L.R, Daynes, R.A, Rosen, C.A, (1991). In vitro activation of HIV-1 long terminal repeat by UV light and various skin applicants in transgenic mice. Journal Acquired Immune Deficiency Syndrome 4:328 *
• Morrey, J.D, (1991). New models of murine cytomegalovirus infection in immunocompromised mice. Antiviral Res. 15(Suppl. 1):133 *
• Morrey, J.D, (1989). Murine retroviral disease enhancing effects of a pyrimidinone immunomodulator. The Pharmacologist *
• Morrey, J.D, (1989). Murine retroviral disease enhancing effects of a pyrimidinone immunomodulator. The Pharmacologist *

An asterisk (*) at the end of a publication indicates that it has not been peer-reviewed.

Publications | Books

• Morrey, J.D, (2002). Ethical Issues in Biotechnology.

Publications | Book Chapters

• Morrey, J.D, (2000). Ethical issues in transgenics. Cloning
• Morrey, J.D, (1999). Animal models for HBV infections - transgenic mice. Handbook of Animal Models of Infection *
• Morrey, J.D, (1998). Transgenic mice as a chemotherapeutic model for HBV infection. Therapies for Viral Hepatitis *
• Morrey, J.D, (1994). Effect of the combination of human recombinant alpha interferon-A/D and 2',3'-didehydro=2',3'-dideoxythymidine on murine retrovirus disease. Recent Advances in Chemotherapy *

An asterisk (*) at the end of a publication indicates that it has not been peer-reviewed.

Publications | Journal Articles

Academic Journal

• Clancy, C.S, Van Wettere, A., Morrey, J.D, Julander, J., (2018). Coitus-Free Sexual Transmission of Zika Virus in a Mouse Model.. Scientific reports, 8:1, 15379.
• Julander, J., Siddharthan, V., Park, A.H, Preston, E., Mathur, P., Bertolio, M., Wang, H., Zukor, K., Van Wettere, A., Sinex, D.G, Morrey, J.D, (2018). Consequences of in utero exposure to Zika virus in offspring of AG129 mice.. Scientific reports, 8:1, 9384.
• Clancy, C.S, Van Wettere, A., Siddharthan, V., Morrey, J.D, Julander, J., (2018). Comparative Histopathologic Lesions of the Male Reproductive Tract during Acute Infection of Zika Virus in AG129 and Ifnar−/− Mice. The American Journal of Pathology, 188:4, 904 - 915.
• Zukor, K., Wang, H., Hurst, B.L, Siddharthan, V., Van Wettere, A., Pilowsky, P.M, Morrey, J.D, (2017). Phrenic nerve deficits and neurological immunopathology associated with acute West Nile virus infection in mice and hamsters. Journal of Neurovirology, 23:2, 186-204.
• Siddharthan, V., Wang, H., Davies, C., Hall, J.O, Morrey, J.D, (2014). Inhibition of West Nile virus by calbindin-D28k. PLOS One, 9, e106535.
• Julander, J., Kesler, K., Van Wettere, A., Morrey, J.D, Smee, D., (2014). The use of plethysmography in determining the severity of lung pathology in a mouse model of minimally lethal influenza virus infection. Antiviral Research, 108, 10-13. doi: 10.1016/j.antiviral.2014.05.002
• Julander, J.G, Kesler, K., Van Wettere, A., Morrey, J.D, Smee, D., (2014). The use of plethysmography in determining the severity of lung pathology in a mouse model of minimally lethal influenza virus infection. Antiviral Research, 108, 10-13.
• Yun, S., Song, B., Kim, J., Yun, G., Lee, E., Li, L., Kuhn, R.J, Rossmann, M.G, Morrey, J.D, Lee, Y., (2014). A molecularly cloned, live-attenuated Japanese encephalitis vaccine SA14-14-2 virus: A conserved single amino acid in the ij hairpin of the viral E glycoprotein determines neurovirulence in mice. PLOS Pathogens (PLOS Pathog), 10:7, e1004290. doi: doi: 10.1371/journal.ppat.1004290
• Julander, J., Thibodeaux, B., Morrey, J.D, Roehrig, J.T, Blair, C.D, (2014). Humanized monoclonal antibody 2C9-cIgG has enhanced efficacy for yellow fever prophylaxis and therapy in an immunocompetent animal model. Antiviral Research, 103, 32-38. doi: 10.1016/j.antiviral.2013.12.011
• Petrovsky, N., Larena, M., Siddharthan, V., Prow, N.A, Hall, R.A, Lobigs, M., Morrey, J.D, (2013). An inactivated cell culture Japanese encephalitis vaccine (JE-ADVAX) formulated with delta inulin adjuvant provides robust heterologous protection against West Nile encephalitis via cross-protective memory B cells and neutralizing antibody.. Journal of Virology, 87, 10324-10333.
• Smee, D., Tarbet, B., Furuta, Y., Morrey, J.D, Barnard, D., (2013). Synergistic combinations of favipiravir and oseltamivir against wild-type pandemic and oseltamivir-resistant influenza A virus infections in mice. Antiviral Research, 8:11, 1085-1094.
• Morrey, J.D, Siddharthan, V., Wang, H., (2013). Neurological approaches for investigating West Nile virus disease and its treatment in rodents. Antiviral Research, 100, 535-535.
• Roth, J.P, Li, J.K, Morrey, J.D, Barnard, D.L, Vollmer, A.H, (2013). Deletion of the D domain of the human parainfluenza virus type 3 (HPIV3) PD protein results in decreased viral RNA synthesis and beta interferon (IFN-b) expression. Virus Genes/Springer, 47, 10. doi: 10.1007/s11262-013-0919-x
• Wang, H., Siddharthan, V., Kessler, K.K, Hall, J.O, Motter, N.E, Julander, J., Morrey, J.D, (2013). Fatal neurological respiratory insufficiency is common among viral encephalitides. The Journal of Infectious Diseases, 208:4, 573-83.
• Tarbet, B., Maekawa, M., Furuta, Y., Babu, Y., Morrey, J.D, Smee, D., (2012). Combinations of Favipiravir and Peramivir for the Treatment of Pandemic Influenza A/California/04/2009 (H1N1) Virus Infections in Mice. . Antiviral Research, 94:(1), 103-110.
• Morrey, J.D, S.V, W.H, Hall, J.O, (2012). Respiratory Insufficiency Correlated Strongly with Mortality of Rodents Infected with West Nile Virus. PLoS ONE , 7:6, e38672. doi: doi:10.1371/journal.pone.0038672
• Kumaki, Y., Craig, D., Morrey, J.D, Smee, D., Barnard, D., (2011). In vitro and in vivo efficacy of fluorodeoxycytidine analogs against highly pathogenic avian influenza H5N1, seasonal, and pandemic H1N1 virus infections. . Antiviral Research/Elsevier, 92:2, 329-340.
• Julander, J., Hagloch, J., Latimer, S., Motter, N., Dagley, A., Barnard, D., Smee, D., Morrey, J.D, (2011). Use of plethysmography in assessing the efficacy of antivirals in a mouse model of pandemic influenza A virus. Antiviral Research, 92:2, 228-36.
• Wang, H., Siddharthan, V., Hall, J.O, Morrey, J.D, (2011). Autonomic nervous dysfunction in hamsters infected with West Nile virus. PLoS ONE, 6, e19575.
• Gowen, B., Julander, J., London, N.R, Wong, M.H, Larson, D., Morrey, J.D, Li, D.Y, Bray, M., (2010). Assessing changes in vascular permeability in a hamster model of viral hemorrhagic fever. Virol. J., 7, 240.
• Moheno, P., Morrey, J.D, Fuchs, D., (2010). Effect of dipterinyl calcium pentahydrate on hepatitis B virus replication in transgenic mice. Journal of Translational Medicine, 8, 32.
• Morrey, J.D, Siddharthan, V., Wang, H., Hall, J.O, Motter, N.E, Skinner, R.D, Skirpstunas, R.T, (2010). Neurological suppression of diaphragm electromyographs in hamsters infected with West Nile virus.. Journal of Neurovirology, 16:4, 318-329.
• Coughlin, J.E, Padmanabhan, S., Zhang, G., Kirt, C.P, Govardhan, B.E, Korba, B.E, O'Loughlin, K., Green, C.E, Mirsalis, J., Morrey, J.D, Iyer, R.P, (2010). Orally bioavailable anti-HBV dinucleotide acyloxyalkyl prodrugs. Bioorg Med Chem Lett, 20, 1783-6.
• Smee, D., Hurst, B.L, Wong, M., Tarbet, B., Babu, Y.S, Klumpp, K., Morrey, J.D, (2010). Combinations of oseltamivir and peramivir for the treatment of influenza A (H1N1) virus infections in cell culture and in mice. Antiviral Res., 88:1, 38-44.
• Gowen, B., Julander, J., London, N.R, Wong, M.H, Larson, D., Morrey, J.D, Li, D.Y, Bray, M., (2010). Assessing changes in vascular permeability in a hamster model of viral hemorrhagic fever. Virol. J., 7:240, 1-13.
• Gowen, B., Wong, M.H, Larson, D., Ye, W., Jung, K.H, Sefing, E.J, Skirpstunas, R., Smee, D., Morrey, J.D, Schneller, S.W, (2010). Development of a new Tacaribe arenavirus infection model and its use to explore antiviral activity of a novel aristeromycin analog. PLoS ONE, 5:9, pii: e12760.
• Lam, A.M, Murakami, E., Espiritu, C., Steuer, H.M, Niu, C., Keilman, M., Bao, H., Zennou, V., Bourne, N., Julander, J., Morrey, J.D, Smee, D., Frick, D.N, Heck, J.A, Wang, P., Nagarathnam, D., Ross, B.S, Sofia, M.J, Otto, M.J, Furman, P.A, (2010). PSI-7851, a pronucleotide of beta-D-2'-fluro-2'-C-methyluridine monophosphate, is a potent and pan-genotype inhibitor of hepatitis C virus replication. Antimicrob. Agents Chemother., 54:8, 3187-3196.
• Julander, J., Jha, A.K, Choi, J.A, Jung, K.H, Smee, D., Morrey, J.D, Chu, C.K, (2010). Efficacy of 2'-C-methylcytidine against yellow fever virus in cell culture and in a hamster model. Antiviral Res., 86:3, 261-267.
• Gowen, B., Wong, M., Jung, K., Smee, D., Morrey, J.D, Furuta, Y., (2010). Efficacy of favipiravir (T-705) and T-1106 pyrazine derivatives in phlebovirus disease models. Antiviral Res., 86:2, 121-127.
• Smee, D., Hurst, B.L, Wong, M., Bailey, K.W, Tarbet, B., Morrey, J.D, Furuta, Y., (2010). Effects of combinations of favipiravir (T-705) and oseltamivir on influenza A (H1N1, H3N2, and H5N1) virus infections in mice. Antimicrob. Agents Chemother., 54:1, 126-133.
• Roth, J.P, Li, J.K, Smee, D.F, Morrey, J.D, Barnard, D.L, (2009). A recombinant, infectious human parainfluenza virus type 3 expressing the enhanced green fluorescent protein for use in high-throughput antiviral assays. Antiviral Research, 82, 12-21.
• Morrey, J.D, (2009). Alkoxyalkyl esters of (S)-HPMPA are potent and selective inhibitors of hepatitis B virus replication in vitro and in transgenic hepatitis B mice in vivo. Antimicrobial Agents and Chemotherapy, 53, 2865-70.
• Mendenhall, M., Wong, M.H, Skirpstunas, R., Morrey, J.D, Gowen, B., (2009). Punta Toro virus (Bunyaviridae, Phlebovirus) infection in mice: strain differences in pathogenesis and host interferon response.. Virology, 395, 143-51.
• Day, C.W, Baric, R., Cai, S.X, Freeman, M., Kumaki, Y., Morrey, J.D, Smee, D., Barnard, D., (2009). A new mouse-adapted strain of SARS-CoV as a lethal model for evaluating antiviral agents in vitro and in vivo . Virology, 395:2, 210-222.
• Morrey, J.D, (2009). A new mouse-adapted strain of SARS-CoV as a lethal model for evaluating antiviral agents in vitro and in vivo. Virology, (accepted)
• Morrey, J.D, (2009). Effect of T-705 on western equine encephalitis in a mouse model. Antiviral Research, 82, 169-71.
• Morrey, J.D, (2009). Effects of combinations of favipiravir (T-705) and oseltamivir on influenza A (H1N1, H3N2, and H5N1) virus infections in mice. Antimicrobial Agents and Chemotherapy, (accepted)
• Morrey, J.D, (2009). Effects of double combinations of amantadine, oseltamivir, and ribavirin on influenza A (H5N1) virus infections in cell culture and in mice. Antimicrobial Agents and Chemotherapy, 53, 2120-8.
• Morrey, J.D, (2009). Efficacy of favipiravir (T-705) and T-1106 pyrazine derivatives in phlebovirus disease models. Antiviral Research, (accepted)
• Morrey, J.D, (2009). Persistent West Nile virus associated with a neurological sequela in hamsters identified by motor unit number estimation. Journal of Virology, 83, 4251-61.
• Morrey, J.D, (2009). Punta toro virus (Bunyaviridae, Phlebovirus) infection in mice: Strain differences in pathogenesis and host interferon response. Virology, (in press Epub)
• Morrey, J.D, (2009). T-705 (favipiravir) and related compounds: Novel broad-spectrum inhibitors of RNA viral infections. Antiviral Research, 82, 95-102.
• Julander, J., Smee, D., Morrey, J.D, Furuta, Y., (2009). Effect of T-705 treatment on western equine encephalitis in a mouse model. Antiviral Res., 82:3, 169-171.
• Furuta, Y., Takahashi, K., Shiraki, K., Sakamoto, K., Smee, D., Barnard, D., Gowen, B., Julander, J., Morrey, J.D, (2009). T-705 (favipiravir) and related compounds: novel broad-spectrum inhibitors of RNA viral infections. Antiviral Res, 82:3, 95-102.
• Smee, D., Hurst, B.L, Wong, M., Bailey, K.W, Morrey, J.D, (2009). Effects of double combinations of amantadine, oseltamivir, and ribavirin on influenza A (H5N1) virus infections in cell culture and in mice. Antimicrob. Agents Chemother., 53, 2120-2128.
• Roth, J.P, Li, J.K, Smee, D., Morrey, J.D, Barnard, D., (2009). A recombinant, infectious human parainfluenza virus type 3 expressing the enhanced green fluorescent protein for use in high-throughput antiviral assays. Antiviral Res., 82:1, 12-21.
• Julander, J., Shafer, K., Smee, D., Morrey, J.D, Furuta, Y., (2009). Activity of T-705 in a hamster model of yellow fever virus infection in comparison with a chemically related compound T-1106. Antimicrob. Agents Chemother., 53:1, 202-209.
• Julander, J., Shafer, K., Smee, D., Morrey, J.D, Furuta, Y., (2009). Activity of T-705 in a hamster model of yellow fever virus infection in comparison with a chemically related compound T-1106. Antimicrob. Agents Chemother., 53:1, 202-209.
• Gowen, B., Fairman, J., Dow, S.W, Troyer , R., Wong, M.H, Jung, K.H, Melby, P.C, Morrey, J.D, (2009). Prophylaxis with cationic liposome-DNA complexes protects hamsters from phleboviral disease: Importance of liposomal delivery and CpG motifs.. Antiviral Res, 81:1, 37-46.
• Morrey, J.D, (2008). West Nile virus-induced acute flaccid paralysis is prevented by monoclonal antibody treatment even after infection of spinal cord neurons. Journal of Neurovirology, 14, 152-63.
• Morrey, J.D, Taro, B.S, Siddharthan, V., Wang, H., Smee, D., Christensen, A.J, Furuta, Y., (2008). Efficacy of orally administered T-705 pyrazine analog on lethal West Nile virus infection in rodents. Antiviral Res., 80:3, 377-379.
• Julander, J., Bowen, R.A, Rao, J.R, Day, C., Shafer, K., Smee, D., Morrey, J.D, Chu, C.K, (2008). Treatment of Venezuelan equine encephalitis virus infection with (-)-carbodine. Antiviral Res., 80:3, 309-315.
• Julander, J., Bowen, R.A, Rao, J.R, Day, C., Shafer, K., Smee, D., Morrey, J.D, Chu, C.K, (2008). Treatment of Venezuelan equine encephalitis virus infection with (-)-carbodine. Antiviral Res., 80:3, 309-315.
• Gowen, B., Smee, D., Wong, M., Hall, J.O, Jung, K., Bailey, K.W, Stevens, J.R, Furuta, Y., Morrey, J.D, (2008). Treatment of late stage disease in a model of arenaviral hemorrhagic fever: T-705 efficacy and reduced toxicity suggests an alternative to ribavirin. PLoS ONE, 3:11, e3725.
• Gowen, B., Judge, J.W, Wong, M.H, Jung, K.H, Aylsworth, C.F, Melby, P.C, Rosenberg, B., Morrey, J.D, (2008). Immunoprophylaxis of Punta Toro virus (Phlebovirus, Bunyaviridae) infection in hamsters with recombinant Eimeria profilin-like antigen.. Int. Immunopharmacol., 8, 1089-94.
• Julander, J., Skirpstunas, R., Siddharthan, V., Shafer, K., Hoopes, J.D, Smee, D., Morrey, J.D, (2008). C3H/HeN mouse model for the evaluation of antiviral agents for the treatment of Venezuelan equine encephalitis virus infection. Antiviral Res., 78:3, 230-241.
• Julander, J., Skirpstunas, R., Siddharthan, V., Shafer, K., Hoopes, J.D, Smee, D., Morrey, J.D, (2008). C3H/HeN mouse model for the evaluation of antiviral agents for the treatment of Venezuelan equine encephalitis virus infection. Antiviral Res., 78:3, 230-241.
• Morrey, J.D, (2008). Activity of T-705 in a hamster model of yellow fever virus infection in comparison with a chemically related compound T-1106. Antimicrobial Agents and Chemotherotherapy, 53, 202-9.
• Morrey, J.D, (2008). C3H/HeN mouse model for the evaluation of antiviral agents for the treatment of Venezuelan equine encephalitis virus infection. Antiviral Research, 78, 230-41.
• Morrey, J.D, (2008). Efficacy of cationic lipd-DNA complexes (CLDC) on hepatitis B virus in transgenic mice. Antiviral Research, 79, 71-9.
• Morrey, J.D, (2008). Efficacy of orally administered T-705 pyrazine analog on lethal West Nile virus infection in rodents. Antiviral Research, 80, 377-9.
• Morrey, J.D, (2008). Immunoprophylaxis of Punta Toro virus (Phlebovirus, Bunyaviridae) infection in hamsters with recombinant Eimeria profilin-like antigen.. International Immunopharmacology, 8, 1089-94.
• Morrey, J.D, (2008). Increased blood-brain-barrier permeability not a primary determinant for lethality of West Nile virus infection of rodents. Journal of General Virology, 89, 467-73.
• Morrey, J.D, (2008). Prophylaxis with cationic liposome-DNA complexes protects hamsters from phleboviral disease: Importance of liposomal delivery and CpG motifs. Antiviral Research, 81, 37-46.
• Morrey, J.D, (2008). Treatment of late stage disease in a model of arenaviral hemorrhagic fever: T-705 efficacy and reduced toxicity suggests an alternative to ribavirin. PLoS One, 3, 3725.
• Morrey, J.D, (2008). Treatment of Venezuelan equine encephalitis virus infection with (-)-carbodine. Antiviral Research, 80, 309-15.
• Morrey, J.D, (2007). Efficacy of orally administered T-705 on lethal avian influenza A (H5N1) virus infections in mice. Antimicrobial Agents and Chemotherapy, 51, 845-51.
• Morrey, J.D, (2007). Axonal transport mediates West Nile virus entry into the central nervous system and induces acute flaccid paralysis.. Proc. Natl. Acad. Sci USA, 104, 17140-5.
• Morrey, J.D, Siddharthan, V., Olsen, A.L, Wang, H., Julander, J., Hall, J.O, Li, H., Nordstrom, J.L, Koenig, S., Johnson, S., Diamond, M.S, (2007). Defining limits of treatment with humanized neutralizing monoclonal antibody for West Nile virus neurological infection in a hamster model.. Antimicrob. Agents Chemother., 51 (7), 2396-402.
• Morrey, J.D, (2007). Caspase-3 dependent cell death of neurons contributes to the pathogenesis of West Nile virus encepthalitis. Journal of Virology, 81, 2614-23.
• Morrey, J.D, (2007). Correlation between breakdown of the blood-brain-barrier and disease outcome of viral encepthalitis in mice. Antiviral Res., 75:104-112
• Morrey, J.D, (2007). Defining the limit of effective treatment for West Nile virus neurological infection with a humanized neutralizing monoclonal antibody.. Antimicrob. Agents Chemother., 51, 2396-2402.
• Morrey, J.D, Siddharthan, V., Olsen, A.L, Roper, G.Y, Wang, H., Baldwin, T.J, Koenig, S., Johnson, S., Nordstrom, J.L, Diamond, M.S, (2007). Humanized monoclonal antibody against West Nile virus E protein administered after neuronal infection protects against lethal encephalitis in hamsters.. The Journal of Infectious Diseases, 194, 1300-8.
• Morrey, J.D, (2007). Neutralizing viruses in suspensions by copper oxide based filters.. Antimicrob Agents Chemother, 51, 2605-2607.
• Julander, J., Siddharthan, V., Blatt, L.M, Shafer, K., Sidwell, R.W, Morrey, J.D, (2007). Effect of exogenous interferon and an interferon inducer on western equine encephalitis virus disease in a hamster model. Virology, 360:2, 454-460.
• Julander, J., Morrey, J.D, Blatt, L.M, Shafer, K., Sidwell, R.W, (2007). Comparison of the inhibitory effects of interferon alfacon-1 and ribavirin on yellow fever virus infection in a hamster model. Antiviral Res., 73:2, 140-146.
• Stuyver, L.J, McBrayer, T.R, Tharnish, P.M, Clark, J., Hollecker, L., Lostia, S., Nachman, T., Grier, J., Bennett, M.A, Xie, M.Y, Schinazi, R.F, Morrey, J.D, Julander, J., Furman, P.A, Otto, M.J, (2006). Inhibition of hepatitis C replicon RNA synthesis by beta-D-2'-deoxy-2'fluoro-2'-C-methylcytidine: a specific inhibitor of hepatitis C virus replication. Antiv. Chem. Chemother., 17:2, 79-87.
• Morrey, J.D, (2006). A porphyrin increases survival time of mice after intracerebral prion infection.. Antimicrobial Agents and Chemotherotherapy, 50, 759-61.
• Morrey, J.D, (2006). Effect of exogenous interferon and an interferon inducer on western equine encephalitis virus disease in a hamster model.. Virology, 360, 454-460.
• Morrey, J.D, (2006). Enhanced antiscrapie effect using combination drug treatment.. Antimicrob Agents Chemother., 50, 3447-3449.
• Morrey, J.D, (2006). Humanized monoclonal antibody against West Nile virus E protein administered after neuronal infection protects against lethal encephalitis in hamsters. Journal of Infectious Disease, 194, 1300-08.
• Morrey, J.D, (2006). Inhibition of hepatitis C replicon RNA synthesis by b-d-2'-deoxy-2'-fluoro-2'-C-methylcytidine: a specific inhibitor of hepatitis C virus replication.. Antiviral Chemistry and Chemotherapy, 17, 79-87.
• Morrey, J.D, (2006). Inhibition of West Nile virus replication by synthetic oligonucleotides. Antiviral Res, 70(2), 60-5.
• Morrey, J.D, (2006). West Nile virus infection of the placenta.. Virology, 347, 175-82.
• Julander, J., Winger, Q.A, Rickords, L.F, Shi, P.Y, Tilgner, M., Binduga-Gajewska, I., Sidwell, R.W, Morrey, J.D, (2006). West Nile virus infection of the placenta.. Virology, 347:1, 175-182.
• Day, C.W, Smee, D., Julander, J., Yamshchikov, V.F, Sidwell, R.W, Morrey, J.D, (2005). Error-prone replication of West Nile virus caused by ribavirin.. Antiviral Res., 67:1, 38-45.
• Morrey, J.D, (2005). Broad-spectrum inhibitor of viruses in the Flaviviridae family. Antiviral Research, 68, 49-55.
• Morrey, J.D, (2005). Error-prone replication of West Nile virus caused by ribavirin. Antiviral Research, 67, 38-45.
• Morrey, J.D, (2005). Nucleotide analogs as novel anti-hepatitis B virus agents.. Current Opinions in Pharmacology, 5, 520-528.
• Morrey, J.D, (2005). Treatment of West Nile virus-infected mice with reactive immumoglobulin reduces fetal titers and increases dam survival. Antiviral Research, 65, 79-85.
• Julander, J., Winger, Q.A, Olsen, A.L, Day, C.W, Sidwell, R.W, Morrey, J.D, (2005). Treatment of West Nile virus-infected mice with reactive immunoglobulin reduces fetal titers and increased dam survival. Antiviral Res., 65:2, 79-85.
• Morrey, J.D, Day, C.W, Julander, J., Olsen, A.L, Sidwell, R.W, Cheney, C.D, Blatt, L.M, (2004). Modeling hamsters for evaluating West Nile virus therapies.. Antiviral Res., 63:1, 41-50. doi: 10.1016/j.antiviral.2004.02.005
• Morrey, J.D, (2004). Anti-hepatitis B virus activity of ORI-9020, a novel phosphorothioate dinucleotide, in a transgenic mouse model. Antimicrobial Agents and Chemotherapy, 48(6), 2318-2320.
• Morrey, J.D, (2004). Effect of interferon-alpha and interferon-inducers on West Nile virus in mouse and hamster animal models. Antiviral Chemistry and Chemotherapy, 15, 101-109.
• Morrey, J.D, (2004). Evaluation of new cell culture inhibitors of protease-resistant prion protein against scrapie infection in mice. Journal of General Virology, 85(Pt 8), 2479-83.
• Morrey, J.D, (2004). Inhibition of severe acute respiratory syndrome-associated coronavirus (SARSCoV) by calpain inhibitors and b-D-N4-hydroxycytidine. Antiviral Chemistry and Chemotherapy, 15, 15-22.
• Morrey, J.D, (2004). Modeling hamsters for evaluating West Nile virus therapies. Antiviral Research, 63(1), 41-50.
• Morrey, J.D, (2004). Phosphorothioate di- and tri-nucleotides as a novel class of anti-HBV agents. Antimicrobial Agents and Chemotherapy, 48(6), 2199-2205.
• Morrey, J.D, (2004). Transgenic HBV mouse model in the study of HBV. Methods in Molecular Medicine: Hepatitis B and D Protocols, 96, 239-52.
• Iyer, R.P, Roland, A., Jin, Y., Mounir, S., Korba, B., Julander, J., Morrey, J.D, (2004). Anti-hepatitis B virus activity of ORI-9020, a novel phosphorothioate dinucleotide, in a transgenic mouse model.. Antimicrob Agents Chemother, 48:6, 2318-2320.
• Morrey, J.D, Day, C.W, Julander, J., Blatt, L.M, Smee, D., Sidwell, R.W, (2004). Effect of interferon-alpha and interferon-inducers on West Nile virus in mouse and hamster animal models.. Antivir Chem Chemother, 15:2, 101-109.
• Julander, J., Colonno, R.J, Sidwell, R.W, Morrey, J.D, (2003). Characterization of antiviral activity of entecavir in transgenic mice expressing hepatitis B virus.. Antiviral Res, 59:3, 155-161.
• Morrey, J.D, (2003). A self-processing ribozyme cassette: utility against human papillomavirus 11 E6/E7 mRNA and hepatitis B virus. Molecular Therapy, 9, 596-606.
• Morrey, J.D, (2003). Inhibition of influenza virus infections in immunosuppressed mice with orally administered Peramivir (BCX-1812). Antiviral Research, 60, 17-25.
• Sidwell, R.W, Bailey, K.W, Morrey, J.D, Wong, M.H, Baldwin, T.J, Smee, D., (2003). Inhibition of influenza virus infections in immunosuppressed mice with orally administered Peramivir (BCX-1812).. Antiviral Research, 60, 17-25.
• Julander, J., Sidwell, R.W, Morrey, J.D, (2002). Characterizing antiviral activity of adefovir dipivoxil in transgenic mice expressing hepatitis B virus. Antiviral Res., 55:1, 27-40.
• Morrey, J.D, (2002). Characterization of antiviral activity of entecavir in transgenic mice expressing hepatitis B virus. Antiviral Research, 59, 155-161.
• Morrey, J.D, (2002). Characterization of nuclease-resistant ribozymes directed against hepatitis B virus RNA. J. Viral. Hepat., 9(6), 411-8.
• Morrey, J.D, (2002). Characterizing antiviral activity of adefovir dipivoxil in transgenic mice expressing hepatitis B Virus. Antiviral Research, 55, 27-40.
• Morrey, J.D, (2002). Identification of active compounds against a New York isolate of West Nile virus. Antiviral Research, 55, 107-116.
• Morrey, J.D, (2001). Appetite is not influenced by a unique milk peptide: caseinomacropeptide (CMP). Appetite, 36(2), 157-63.
• Morrey, J.D, (2001). Enantiomeric synthesis of D- and L-cyclopentenyl nucleosides and their antiviral activity against HIV and West Nile virus. J. Med. Chem., 44(23), 3985-3993.
• Morrey, J.D, (2001). In vivo influenza virus-inhibitory effects of the cyclopentane neuraminidase inhibitor RJW-270201. Antimicrobial Agents and Chemotherapy, 45(3), 749-57.
• Morrey, J.D, (2001). Influence of virus strain, challenge dose, and time of therapy initiation on the in vivo influenza inhibitory effects of RWH-270201. Antiviral Research, 51, 179-187.
• Morrey, J.D, (2001). Transgenic mice carrying a gene for green fluorescent protein fused to a lytic peptide, shiva 1, under control of the bovine B-casein regulatory region. Transgenics, 3, 183-197.
• Morrey, J.D, (1999). Development of nuclear transfer and parthenogenetic rabbit embryos activated with inositol 1,4,5-trisphophate. Biology of Reproduction, 60, 821-827.
• Morrey, J.D, (1999). Resistance to Friend leukemia virus in transgenic mice expressing the native FV-4 gene. Acta Virologica, 43, 19-23.
• Morrey, J.D, (1999). Utilization of transgenic mice replicating high levels of hepatitis B virus for antiviral evaluation of lamivudine. Antiviral Research, 42, 97-108.
• Morrey, J.D, (1997). Interleukin 2 promoter/enhancer controlled expression of a synthetic cecropin-class lytic peptide in transgenic mice and subsequent resistance to Brucella abortus.. Transgenic Research, 6, 337-347.
• Morrey, J.D, (1996). Progression of Aleutian mink disease in natural and experimental infections. Amer. J. of Vet. Res., 57, 1753-1758.
• Morrey, J.D, (1996). Progression of Aleutian mink disease in natural and experimental infections. Amer. J. of Vet. Res., 57, 1753-1758.
• Morrey, J.D, (1995). Activation of the human immunodeficiency virus long terminal repeat by abrasion of the skin in transgenic mice. Intervirology, 37, 315-320.
• Morrey, J.D, (1995). Special Topics Issue, Cell Biology of Embryogenesis. Theriogenology 48:1059-1212, 48, 1059-1212.
• Bunch, T.D, White, K.L, Morrey, J.D, Barnes, F.L, (1995). Special Topics Issue, Cell Biology of Embryogenesis. Theriogenology, 48, 1059-1212.
• Morrey, J.D, (1994). Importance of primer selection in application of PCR technology to diagnosis of bovine leukemia virus. Journal of Veterinary Diagnostic Investigation, 6, 297-301.
• Morrey, J.D, (1993). Activation of the human immunodeficiency virus type 1 long terminal repeat by skin-sensitizing chemicals in transgenic mice. Intervirology, 36, 65-71.
• Morrey, J.D, Jackson, M.K, Bunch, T.D, Sidwell, R.W, (1993). Activation of the human immunodeficiency virus type 1 long terminal repeat by skin-sensitizing chemicals in transgenic mice. Intervirol., 36, 65-71.
• Morrey, J.D, (1993). Aleutian Disease: Current Status and Developments. Blue Book of Farming, 1, 5-Apr.
• Morrey, J.D, (1993). Early detection of bovine leukemia virus in experimentally infected cattle by use of the polymerase chain reaction. Amer. J. of Vet. Res., 54, 205-209.
• Morrey, J.D, (1993). Early detection of bovine leukemia virus in experimentally infected cattle by use of the polymerase chain reaction. Amer. J. of Vet. Res., 54, 205-209.
• Morrey, J.D, (1993). Effect of immunomodulators in the hu-PBL-SCID mouse model. Biotechnology Therapeutics, 4, 133-143.
• Morrey, J.D, (1993). Immunomodulator effects on the Friend virus infection in genetically defined mice. Ann. N.Y. Acad. Sci., 685, 432-446.
• Morrey, J.D, (1992). Elucidation of mode of retroviral-inhibitory effects of imexon through use of immune competent and severe combined immune deficiency (SCID) mice. Antiviral Research, 17, 223-233.
• Morrey, J.D, (1992). Experiences with biological response modifiers in animal models for AIDS.. Recent Adv. Chemother., 1, 934-935.
• Morrey, J.D, (1992). Ganciclovir treatment of murine cytomegalovirus infection in mice immunosuppressed by prior infection with friend leukemia virus. Antiviral Chemistry and Chemotherapy, 3, 327-333.
• Morrey, J.D, (1992). HIV-1 LTR activation model: Evaluation of various agents in skin of transgenic mice. Journal of Acquired Immune Deficiency Syndromes, 5, 1195-1203.
• Morrey, J.D, Bourn, S.M, Bunch, T.D, Sidwell, R.W, Rosen, C.A, (1992). HIV-1 LTR activation model: Evaluation of various agents in skin of transgenic mice. J. of AIDS., 5, 1195-1203.
• Morrey, J.D, (1992). Murine retroviral disease enhancing effects of a pyrimidinone immunomodulator. Antiviral Research, 19, 233-245.
• Morrey, J.D, (1992). Suppression of murine retroviral disease by 2', 3'-dideoxythymidine (D4T).. Antiviral Research, 19, 313-324.
• Morrey, J.D, (1991). Early-initiated Zidovudine therapy prevents disease but not low levels of persistent retrovirus in mice. Journal of Acquired Immune Deficiency Syndromes, 4, 506-512.
• Morrey, J.D, (1991). In vivo activation of human immunodeficiency virus type 1 long terminal repeat by UV type A (UV-A) light plus psoralen and UV-B light in the skin of transgenic mice. Journal of Virology, 65, 5045-5051.
• Morrey, J.D, Bourn, S.M, Bunch, T.D, Sidwell, R.W, Barrows, L.R, Daynes, R.A, Rosen, C.A, (1991). In vivo activation of human immunodeficiency virus type 1 long terminal repeat by UV type A (UV-A) light plus psoralen and UV-B light in the skin of transgenic mice. J. Virol., 65, 5045-5051.
• Morrey, J.D, (1991). In vivo regulation of HIV-1 long terminal repeat by UV light and various skin applicants in transgenic mice. Journal of Acquired Immune Deficiency Syndromes, 4, 328-329.
• Morrey, J.D, Bourn, S.M, Bunch, T.D, Sidwell, R.W, Barrows, L.R, Daynes, R.A, Rosen, C.A, (1991). In vivo regulation of HIV-1 long terminal repeat by UV light and various skin applicants in transgenic mice. J. AIDS., 4, 328.
• Morrey, J.D, (1991). Two-cell blockage of FVB/N embryo development: An artifact of cell culture. Encylcia, 78, 275-284.
• Morrey, J.D, Bourn, S., Sidwell, R.W, Sisson, D.V, Bunch, T.D, Flood, M.R, (1991). Two-cell blockage of FVB/N mouse embryo development: An artifact of cell culture. Encylia., 68, 275-284.
• Morrey, J.D, (1990). A mouse genetics model for evaluation of biological response modifiers for the treatment of retroviral infection. J. Cell. Biochem., 140, 68-70.
• Morrey, J.D, (1990). Effect of Imexon on friend virus complex infection in Rfv-3r/s genotype-containing mice as a model for AIDS. Ann. N.Y. Acad. Sci. 616:575-578, 616, 575-578.
• Morrey, J.D, (1990). Effect of imexon treatment on Friend virus infection using genetically defined mice as a model for HIV infection. Antiviral Research, 15, 51-66.
• Morrey, J.D, (1990). Effects of zidovudine on Friend virus complex infection in Rfv-3r/s genotype-containing mice used as a model for HIV infection. Journal of Acquired Immune Deficiency Syndromes, 3, 500-510.
• Morrey, J.D, (1987). Staphylococcus of turkeys: 1. Portal of entry and tissue colonization.. Journal of Avian Diseases, 31, 64-69.
• Morrey, J.D, (1987). Tissue-specific replication of Friend and Moloney murine leukemia viruses in infected mice.. Journal of Virology, 61, 1350-1357.
• Morrey, J.D, (1984). Effects of folic acid malnutrition on rotaviral infection in mice. Proceedings of the Society of Experimental Biology and Medicine, 1766, 77-83.

Professional Journal

• Julander, J., Bantia, S., Taubenheim, B.R, Minning, D.M, Kotian, P., Morrey, J.D, Smee, D., Sheridan, W.P, Babu, Y.S, (2014). BCX4430, a novel nucleoside analog, effectively treats yellow fever in a hamster model. Antimicrobial Agents and Chemotherapy, 58:11, 6607-6614.
• Wang, H., Siddharthan, V., Kesler, K., Hall, J.O, Motter, N.E, Julander, J., Morrey, J.D, (2013). Autonomic Deficit not the Cause of Death in West Nile Virus Neurological Disease. J Infect Dis, 204:4, 573-583.
• Wand, H., Siddharthan, V., Kesler, K., Hall, J.O, Motter, N.E, Julander, J., Morrey, J.D, (2013). Autonomic Deficit not the Cause of Death in West Nile Virus Neurological Disease. J Infect Dis, 204:4, 573-583.
• Julander, J., Ennis, J., Turner, J., Morrey, J.D, (2011). Treatment of yellow fever virus with an adenovirus-vectored interferon, DEF201, in a hamster model. Antimicrob. Agents Chemother., 55:5, 2067-73.
• Wang, H., Siddharthan, V., Hall, J.O, Morrey, J.D, (2009). West Nile virus preferentially transports along motor neuron axons after sciatic nerve injection of hamsters. Journal of Neurovirology, 15, 293-4.
• Morrey, J.D, (1992). Early detection of Aleutian disease virus in mink by polymerase chain reaction. Nor. J. Agr. Sci., 9, 383-387. *

An asterisk (*) at the end of a publication indicates that it has not been peer-reviewed.

Publications | Technical Reports

Research Reports

• Morrey, J.D, Barnard, D., Smee, D., Gowen, B., (2009). Annual Report NO1-AI-15435, NIAID, NIH. Animals Models of Human Experimental Viral Infections for Evaluation of Experimental Therapies.
• Smee, D., Barnard, D., Morrey, J.D, Gowen, B., Julander, J., (2009). Annual Report NO1-AI-85348, NIAID, NIH. In vitro antiviral screen for respiratory viruses. .
• Morrey, J.D, Barnard, D., Morrey, J.D, Smee, D., Gowen, B., (2009). Semi-Annual Report NO1-AI-15435, NIAID, NIH. Animals Models of Human Experimental Viral Infections for Evaluation of Experimental Therapies.
• Morrey, J.D, Barnard, D., Morrey, J.D, Smee, D., Gowen, B., (2009). Semi-Annual Report NO1-AI-15435, NIAID, NIH. Animals Models of Human Experimental Viral Infections for Evaluation of Experimental Therapies.
• Smee, D., Barnard, D., Morrey, J.D, Gowen, B., Julander, J., (2009). Semi-Annual Report NO1-AI-85348, NIAID, NIH. In vitro antiviral screen for respiratory viruses. .
• Morrey, J.D, Barnard, D., Smee, D., Gowen, B., (2008). Annual Report NO1-AI-15435, NIAID, NIH. Animals Models of Human Experimental Viral Infections for Evaluation of Experimental Therapies.
• Morrey, J.D, Barnard, D., Smee, D., Gowen, B., (2008). Annual Report NO1-AI-15435, NIAID, NIH. Animals Models of Human Experimental Viral Infections for Evaluation of Experimental Therapies.
• Smee, D., Barnard, D., Morrey, J.D, Gowen, B., Julander, J., (2008). Annual Report NO1-AI-85348, NIAID, NIH. In vitro antiviral screen for respiratory viruses. .
• Morrey, J.D, Barnard, D., Morrey, J.D, Smee, D., Gowen, B., (2008). Semi-Annual Report NO1-AI-15435, NIAID, NIH. Animals Models of Human Experimental Viral Infections for Evaluation of Experimental Therapies.
• Morrey, J.D, Barnard, D., Morrey, J.D, Smee, D., Gowen, B., (2008). Semi-Annual Report NO1-AI-15435, NIAID, NIH. Animals Models of Human Experimental Viral Infections for Evaluation of Experimental Therapies.
• Smee, D., Barnard, D., Morrey, J.D, Gowen, B., Julander, J., (2008). Semi-Annual Report NO1-AI-85348, NIAID, NIH. In vitro antiviral screen for respiratory viruses. .
• Morrey, J.D, Barnard, D., Smee, D., Gowen, B., (2007). Annual Report NO1-AI-15435, NIAID, NIH. Animals Models of Human Experimental Viral Infections for Evaluation of Experimental Therapies.
• Smee, D., Barnard, D., Morrey, J.D, Gowen, B., Julander, J., (2007). Annual Report NO1-AI-85348, NIAID, NIH. In vitro antiviral screen for respiratory viruses. .
• Morrey, J.D, Barnard, D., Smee, D., Gowen, B., (2007). Semi-Annual Report NO1-AI-15435, NIAID, NIH. Animals Models of Human Experimental Viral Infections for Evaluation of Experimental Therapies.
• Smee, D., Barnard, D., Morrey, J.D, Gowen, B., Julander, J., (2007). Semi-Annual Report NO1-AI-85348, NIAID, NIH. In vitro antiviral screen for respiratory viruses. .
• Sidwell, R., Barnard, D., Morrey, J.D, Smee, D., Gowen, B., (2006). Annual Report NO1-AI-15435, NIAID, NIH. Animals Models of Human Experimental Viral Infections for Evaluation of Experimental Therapies.
• Sidwell, R., Barnard, D., Morrey, J.D, Smee, D., Gowen, B., Julander, J., (2006). Annual Report NO1-AI-85348, NIAID, NIH. In vitro antiviral screen for respiratory viruses. .
• Sidwell, R., Barnard, D., Morrey, J.D, Smee, D., Gowen, B., Julander, J., (2006). Semi Annual Report NO1-AI-85348, NIAID, NIH. In vitro antiviral screen for respiratory viruses. .
• Sidwell, R., Barnard, D., Morrey, J.D, Smee, D., Gowen, B., (2006). Semi-Annual Report NO1-AI-15435, NIAID, NIH. Animals Models of Human Experimental Viral Infections for Evaluation of Experimental Therapies.
• Sidwell, R., Barnard, D., Morrey, J.D, Smee, D., Gowen, B., (2005). Annual Report NO1-AI-15435, NIAID, NIH. Animals Models of Human Experimental Viral Infections for Evaluation of Experimental Therapies.
• Sidwell, R., Barnard, D., Morrey, J.D, Smee, D., Gowen, B., (2005). Semi Annual Report NO1-AI-85348, NIAID, NIH. In vitro antiviral screen for respiratory viruses. .
• Sidwell, R., Barnard, D., Morrey, J.D, Smee, D., Gowen, B., (2005). Semi-Annual Report NO1-AI-15435, NIAID, NIH. Animals Models of Human Experimental Viral Infections for Evaluation of Experimental Therapies.
• Sidwell, R., Barnard, D., Morrey, J.D, Smee, D., Gowen, B., (2004). Annual Report NO1-AI-15435, NIAID, NIH. Animals Models of Human Experimental Viral Infections for Evaluation of Experimental Therapies.
• Sidwell, R., Barnard, D., Morrey, J.D, Smee, D., Gowen, B., (2004). Annual Report NO1-AI-85348, NIAID, NIH. In vitro antiviral screen for respiratory viruses. .
• Sidwell, R., Barnard, D., Morrey, J.D, Smee, D., Gowen, B., (2004). Semi Annual Report NO1-AI-85348, NIAID, NIH. In vitro antiviral screen for respiratory viruses. .
• Sidwell, R., Barnard, D., Morrey, J.D, Smee, D., Gowen, B., (2004). Semi-Annual Report NO1-AI-15435, NIAID, NIH. Animals Models of Human Experimental Viral Infections for Evaluation of Experimental Therapies.
• Sidwell, R., Barnard, D., Morrey, J.D, Smee, D., Gowen, B., (2003). Annual Report NO1-AI-85348, NIAID, NIH. In vitro antiviral screen for respiratory viruses. .
• Sidwell, R., Barnard, D., Morrey, J.D, Smee, D., Gowen, B., (2003). Semi Annual Report NO1-AI-85348, NIAID, NIH. In vitro antiviral screen for respiratory viruses. .
• Sidwell, R., Barnard, D., Morrey, J.D, Smee, D., Gowen, B., (2002). Annual Report NO1-AI-85348, NIAID, NIH. In vitro antiviral screen for respiratory viruses. .
• Sidwell, R., Barnard, D., Morrey, J.D, Smee, D., Gowen, B., (2002). Semi Annual Report NO1-AI-85348, NIAID, NIH. In vitro antiviral screen for respiratory viruses. .
• Sidwell, R., Barnard, D., Morrey, J.D, Smee, D., Gowen, B., (2001). Annual Report NO1-AI-85348, NIAID, NIH. In vitro antiviral screen for respiratory viruses. .
• Sidwell, R., Barnard, D., Morrey, J.D, Smee, D., Gowen, B., (2001). Semi Annual Report NO1-AI-85348, NIAID, NIH. In vitro antiviral screen for respiratory viruses. .
• Sidwell, R., Barnard, D., Morrey, J.D, Smee, D., Gowen, B., (2000). Annual Report NO1-AI-85348, NIAID, NIH. In vitro antiviral screen for respiratory viruses. .
• Sidwell, R., Barnard, D., Morrey, J.D, Smee, D., Gowen, B., (2000). Semi Annual Report NO1-AI-85348, NIAID, NIH. In vitro antiviral screen for respiratory viruses. .
• Sidwell, R., Barnard, D., Morrey, J.D, Smee, D., Gowen, B., (1999). Annual Report NO1-AI-85348, NIAID, NIH. In vitro antiviral screen for respiratory viruses. .
• Sidwell, R., Barnard, D., Morrey, J.D, Smee, D., Gowen, B., (1999). Semi Annual Report NO1-AI-85348, NIAID, NIH. In vitro antiviral screen for respiratory viruses. .

An asterisk (*) at the end of a publication indicates that it has not been peer-reviewed.

Publications | Other

Other

• Morrey, J.D, (1999). Transgenic mice as a chemotherapeutic model for hepatitis B virus infection. Antiviral Ther. *
• Morrey, J.D, (1998). Protein Production in the Milk of Genetically Engineered Animals. M.S., Animal Science, Dept. of Animal, Dairy & Veterinary Sciences, Utah State University, Logan, UT *
• Morrey, J.D, (1998). Protein Production in the Milk of Genetically Engineered Animals. M.S., Animal Science, Dept. of Animal, Dairy & Veterinary Sciences, Utah State University, Logan, UT *
• Morrey, J.D, (1995). Effect of the combination of interferon-alpha and stavudine on Friend virus infections in (B10.A X A.By)F1 mice. Journal of Infectious Diseases *
• Morrey, J.D, (1994). Cytokines as potential therapies for human immunodeficiency virus infections. Canadian Journal of Infectious Diseases *
• Morrey, J.D, (1992). Early detection of Aleutian disease virus in mink by polymerase chain reaction. Nor. J. Agr. Sci. *
• Morrey, J.D, (1992). Transgenic mice as models for photo-induced gene expression: Activation of human immunodeficiency virus long terminal repeat. Journal of Photochemistry and Photobiology *
• Morrey, J.D, Bourn, S.M, Jackson, M.K, Bunch, T.D, Sidwell, R.W, Barrows, L.R, Daynes, R.A, (1992). Transgenic mice as models for photo-induced gene expression: Activation of human immunodeficiency virus long terminal repeat. J. of Photochemistry and Photobiology *
• Morrey, J.D, (1991). New models of murine cytomegalovirus infection in immunocompromised mice. Antiviral Res. 15(Suppl. 1):133 *

An asterisk (*) at the end of a publication indicates that it has not been peer-reviewed.